Total Hip Registry

Osteoarthritis Clinical Trial

Official title:

Total Hip Registry

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT01133249
• Other study ID #: 05-09-01
• Status: Enrolling by invitation
• Phase: N/A
• First received: May 26, 2010
• Last updated: July 22, 2016
• Start date: July 2005
• Est. completion date: December 2018

Study information

• Verified date: July 2016
• Source: Heekin Orthopedic Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Objective

Describe the clinical and demographic characteristics of patients who undergo hip arthroplasty and document post operative outcomes.

Examine the relationship between processes of care, hospital and surgeon associated outcomes

Provide expanded data to characterize existing and evolving practice patterns, delivery of care, and resource utilization in the management of knee arthroplasty patients.

Analyze and design ancillary studies to address unanswered questions.

Disseminate findings through publication in peer-reviewed scientific journals.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 942
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 21 Years to 93 Years

Eligibility

Inclusion Criteria:

• Patient requires total hip Arthroplasty

• Patient has signed IRB approved informed consent

Exclusion Criteria:

• Less than 21 years of age

• Patient is a prisoner

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Osteoarthritis

Locations

Country	Name	City	State
United States	Heekin Orthopedic Specialists	Jacksonville	Florida

Sponsors (4)

Lead Sponsor	Collaborator
Heekin Orthopedic Research Institute	ConforMIS, Inc., DePuy Orthopaedics, Stryker Orthopaedics

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Harris Hip Score		2 weeks, 6 weeks, 3 months, 6 months, 1, 2, 5, 10 years	No